“It’s saving the government money, so they don’t
have an incentive to change it,” Carlton
Sedberry, senior director at Medical Marketing
Economics, a consulting firm, tells The New York
Times. “It’s making the hospitals money, so they
don’t have an incentive to change it… The only
people this smacks are the manufacturers.”
http://www.pharmalot.com/2013/02/now-pharma-takes-a-whack-at-the-340b-program/
Powered by LSoft's LISTSERV(R) list management software